Top Markets
Coin of the day
Liminatus Pharma, Inc. Class A Common Stock Liminatus Pharma, Inc. Class A Common Stock

Liminatus Pharma, Inc. Class A Common Stock

LIMN
Classement en actions #32712
Liminatus Pharma, Inc. is an immuno-oncology firm, currently in its clinical... Liminatus Pharma, Inc. is an immuno-oncology firm, currently in its clinical development phase, dedicated to pioneering new treatments for cancer. The company's headquarters are located in La Palma, California.
Prix de l'action
$0.1363
Capitalisation boursière
$9.15M
Changement (1 jour)
-2.64%
Changement (1 an)
-96.59%
Pays
US
Échange Liminatus Pharma, Inc. Class A Common Stock (LIMN)

Catégorie

Le prix LIMN avec la capitalisation boursière de B
Liminatus Pharma, Inc. Class A Common Stock Liminatus Pharma, Inc. Class A Common Stock
LIMN
$0.1363
Capitalisation boursière de Liminatus Pharma, Inc. Class A Common Stock(LIMN)
Capitalisation boursière: $9.15M
En August 2026, Liminatus Pharma, Inc. Class A Common Stock a une capitalisation boursière de $9.15M. Cela fait de Liminatus Pharma, Inc. Class A Common Stock la 32712th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Liminatus Pharma, Inc. Class A Common Stock du 2025 au 2026
LIMN par rapport au top 5 des plus populaires stocks
Prix pour LIMN L’actif B La capitalisation boursière de B Résultats
Liminatus Pharma, Inc. Class A Common Stock Liminatus Pharma, Inc. Class A Common Stock
$81,382.99 $9.15M
$5.466T +59,708,623.79%
Liminatus Pharma, Inc. Class A Common Stock Liminatus Pharma, Inc. Class A Common Stock
$66,814.43 $9.15M
$4.487T +49,020,021.87%
Liminatus Pharma, Inc. Class A Common Stock Liminatus Pharma, Inc. Class A Common Stock
$61,652.24 $9.15M
$4.141T +45,232,652.30%
Liminatus Pharma, Inc. Class A Common Stock Liminatus Pharma, Inc. Class A Common Stock
$53,095.27 $9.15M
$3.566T +38,954,612.67%
Liminatus Pharma, Inc. Class A Common Stock Liminatus Pharma, Inc. Class A Common Stock
$41,599.45 $9.15M
$2.794T +30,520,406.41%